Brooks Laboratories Limited (NSE:BROOKS)

Brooks Laboratories Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	4,383	2,457	1,540	1,801	1,514	377
Market Cap Growth	25.45%	59.50%	-14.47%	18.92%	301.97%	-56.58%
Enterprise Value	4,465	2,494	2,350	2,300	1,761	672
Last Close Price	147.19	93.60	61.76	72.21	60.72	15.11
PS Ratio	5.70	3.09	2.44	1.98	1.96	0.54
PB Ratio	7.40	3.75	2.08	1.34	1.91	0.38
P/TBV Ratio	7.41	3.75	2.09	2.07	1.93	0.38
P/OCF Ratio	-	-	-	-	33.96	-
EV/Sales Ratio	5.80	3.14	3.72	2.52	2.28	0.96
EV/EBITDA Ratio	-	69.71	-	-	558.45	-
EV/EBIT Ratio	-	119.09	-	-	-	-
Debt / Equity Ratio	0.15	0.09	0.09	0.19	0.52	0.28
Debt / EBITDA Ratio	14.36	1.47	-	-	74.84	-
Asset Turnover	-	0.80	0.41	0.51	0.48	0.43
Inventory Turnover	-	5.45	2.70	2.50	2.60	3.96
Quick Ratio	-	0.79	0.40	0.44	0.24	0.49
Current Ratio	-	1.35	0.84	1.25	0.78	0.83
Return on Equity (ROE)	-	-28.08%	-29.81%	-18.09%	-21.82%	-23.95%
Return on Assets (ROA)	-	1.31%	-13.67%	-7.46%	-2.56%	-3.44%
Return on Capital (ROIC)	2.28%	1.73%	-17.39%	-9.54%	-3.33%	-4.27%
Return on Capital Employed (ROCE)	-	3.10%	-	-	-	-
Earnings Yield	-4.13%	-7.98%	-13.56%	-6.27%	-12.80%	-64.71%
FCF Yield	-	-4.12%	-9.71%	-36.12%	-0.76%	-31.78%
Buyback Yield / Dilution	-2.88%	-3.70%	-	-	-40.27%	-8.80%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.